The Global Liquid Biopsy market is expected to increase at a CAGR of 24.3% in the forecast period of 2016-2021
According to the report "Liquid Biopsy Market", published by Market Data Forecast, the global market is projected to reach USD 1.75 Billion by 2021, at a CAGR of 24.3% from 2016 to 2021.
(EMAILWIRE.COM, April 20, 2017 ) According to the report Liquid Biopsy Market, published by Market Data Forecast, the global market is projected to reach USD 1.75 Billion by 2021, at a CAGR of 24.3% from 2016 to 2021.
For full report refer to http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/
Liquid biopsies have been an advancement in cancer treatment. By means of a simple blood draw, liquid biopsies aim to replace needle biopsies of solid tumours, which can be expensive for the healthcare system as well as invasive and painful for patients. Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/request-sample
Liquid biopsies have grown in importance because, the genetic profile of tumours can affect how well they respond to a certain treatment. Increasing prevalence of various cancers such as lung cancer, breast cancer and prostate cancer is expected to drive growth of the liquid biopsy test market over the forecast period.
Request Customization at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/customize-report
Global Market for Liquid Biopsy is segmented by type of cancer, sample type, diagnostic approach, end users and region
By Cancer Type:
Lung Cancer
Pancreatic Cancer
Leukemia
Other Visceral Cancers
By Sample Type:
Blood
Urine
Plasma
Saliva
Cerebrospinal
By Diagnostic Approach:
Circulating Tumour cells (CTC)
Circulating Tumour DNA (ctDNA)
RNA in exosomes
Extra-Cellular Vesicles
By End Users:
Reference Laboratories
Hospital/Physician Laboratories
Academic and Research Centers
Other End Users
By Geography:
North America
Europe
Asia-Pacific
Latin America
Middle-East and Africa
Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/inquire
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Buy now https://www.marketdataforecast.com/cart/buy-now/global-liquid-biopsy-market-950
About us:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
For full report refer to http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/
Liquid biopsies have been an advancement in cancer treatment. By means of a simple blood draw, liquid biopsies aim to replace needle biopsies of solid tumours, which can be expensive for the healthcare system as well as invasive and painful for patients. Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/request-sample
Liquid biopsies have grown in importance because, the genetic profile of tumours can affect how well they respond to a certain treatment. Increasing prevalence of various cancers such as lung cancer, breast cancer and prostate cancer is expected to drive growth of the liquid biopsy test market over the forecast period.
Request Customization at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/customize-report
Global Market for Liquid Biopsy is segmented by type of cancer, sample type, diagnostic approach, end users and region
By Cancer Type:
Lung Cancer
Pancreatic Cancer
Leukemia
Other Visceral Cancers
By Sample Type:
Blood
Urine
Plasma
Saliva
Cerebrospinal
By Diagnostic Approach:
Circulating Tumour cells (CTC)
Circulating Tumour DNA (ctDNA)
RNA in exosomes
Extra-Cellular Vesicles
By End Users:
Reference Laboratories
Hospital/Physician Laboratories
Academic and Research Centers
Other End Users
By Geography:
North America
Europe
Asia-Pacific
Latin America
Middle-East and Africa
Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/inquire
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Buy now https://www.marketdataforecast.com/cart/buy-now/global-liquid-biopsy-market-950
About us:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results